1. Home
  2. HRTX vs NCV Comparison

HRTX vs NCV Comparison

Compare HRTX & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • NCV
  • Stock Information
  • Founded
  • HRTX 1983
  • NCV 2003
  • Country
  • HRTX United States
  • NCV United States
  • Employees
  • HRTX N/A
  • NCV N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • NCV Finance Companies
  • Sector
  • HRTX Health Care
  • NCV Finance
  • Exchange
  • HRTX Nasdaq
  • NCV Nasdaq
  • Market Cap
  • HRTX 270.7M
  • NCV 321.7M
  • IPO Year
  • HRTX 1987
  • NCV N/A
  • Fundamental
  • Price
  • HRTX $1.73
  • NCV $13.92
  • Analyst Decision
  • HRTX Strong Buy
  • NCV
  • Analyst Count
  • HRTX 3
  • NCV 0
  • Target Price
  • HRTX $5.67
  • NCV N/A
  • AVG Volume (30 Days)
  • HRTX 1.2M
  • NCV 405.1K
  • Earning Date
  • HRTX 02-27-2025
  • NCV 01-01-0001
  • Dividend Yield
  • HRTX N/A
  • NCV 12.48%
  • EPS Growth
  • HRTX N/A
  • NCV N/A
  • EPS
  • HRTX N/A
  • NCV N/A
  • Revenue
  • HRTX $137,737,000.00
  • NCV N/A
  • Revenue This Year
  • HRTX $13.10
  • NCV N/A
  • Revenue Next Year
  • HRTX $14.03
  • NCV N/A
  • P/E Ratio
  • HRTX N/A
  • NCV N/A
  • Revenue Growth
  • HRTX 12.13
  • NCV N/A
  • 52 Week Low
  • HRTX $1.04
  • NCV $2.84
  • 52 Week High
  • HRTX $3.93
  • NCV $3.59
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 52.86
  • NCV 40.15
  • Support Level
  • HRTX $1.63
  • NCV $13.69
  • Resistance Level
  • HRTX $1.83
  • NCV $14.23
  • Average True Range (ATR)
  • HRTX 0.10
  • NCV 0.25
  • MACD
  • HRTX -0.01
  • NCV -0.04
  • Stochastic Oscillator
  • HRTX 41.94
  • NCV 25.27

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About NCV Virtus Convertible & Income Fund of Beneficial Interest

Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.

Share on Social Networks: